Structurally Distinct Hybrid Polymer/Lipid Nanoconstructs Harboring a Type-I Ribotoxin as Cellular Imaging and Glioblastoma-Directed Therapeutic Vectors
2014; Wiley; Volume: 14; Issue: 12 Linguagem: Inglês
10.1002/mabi.201400248
ISSN1616-5195
AutoresM. Sheikh Mohamed, Srivani Veeranarayanan, Ankur Baliyan, Aby Cheruvathoor Poulose, Yutaka Nagaoka, Hiroaki Minegishi, Seiki Iwai, Yasuhiro Shimane, Yasuhiko Yoshida, Toru Maekawa, D. Sakthi Kumar,
Tópico(s)Toxin Mechanisms and Immunotoxins
ResumoMacromolecular BioscienceVolume 14, Issue 12 p. 1696-1711 Full Paper Structurally Distinct Hybrid Polymer/Lipid Nanoconstructs Harboring a Type-I Ribotoxin as Cellular Imaging and Glioblastoma-Directed Therapeutic Vectors M. Sheikh Mohamed, M. Sheikh Mohamed Bio Nano Electronics Research Center, Graduate School of Interdisciplinary New Science Toyo University, Kawagoe, Saitama, 350-8585 JapanSearch for more papers by this authorSrivani Veeranarayanan, Srivani Veeranarayanan Bio Nano Electronics Research Center, Graduate School of Interdisciplinary New Science Toyo University, Kawagoe, Saitama, 350-8585 JapanSearch for more papers by this authorAnkur Baliyan, Ankur Baliyan Bio Nano Electronics Research Center, Graduate School of Interdisciplinary New Science Toyo University, Kawagoe, Saitama, 350-8585 JapanSearch for more papers by this authorAby Cheruvathoor Poulose, Aby Cheruvathoor Poulose Bio Nano Electronics Research Center, Graduate School of Interdisciplinary New Science Toyo University, Kawagoe, Saitama, 350-8585 JapanSearch for more papers by this authorYutaka Nagaoka, Yutaka Nagaoka Bio Nano Electronics Research Center, Graduate School of Interdisciplinary New Science Toyo University, Kawagoe, Saitama, 350-8585 JapanSearch for more papers by this authorHiroaki Minegishi, Hiroaki Minegishi Bio Nano Electronics Research Center, Graduate School of Interdisciplinary New Science Toyo University, Kawagoe, Saitama, 350-8585 JapanSearch for more papers by this authorSeiki Iwai, Seiki Iwai Bio Nano Electronics Research Center, Graduate School of Interdisciplinary New Science Toyo University, Kawagoe, Saitama, 350-8585 JapanSearch for more papers by this authorYasuhiro Shimane, Yasuhiro Shimane Bio Nano Electronics Research Center, Graduate School of Interdisciplinary New Science Toyo University, Kawagoe, Saitama, 350-8585 JapanSearch for more papers by this authorYasuhiko Yoshida, Yasuhiko Yoshida Bio Nano Electronics Research Center, Graduate School of Interdisciplinary New Science Toyo University, Kawagoe, Saitama, 350-8585 JapanSearch for more papers by this authorToru Maekawa, Toru Maekawa Bio Nano Electronics Research Center, Graduate School of Interdisciplinary New Science Toyo University, Kawagoe, Saitama, 350-8585 JapanSearch for more papers by this authorD. Sakthi Kumar, Corresponding Author D. Sakthi Kumar [email protected] Bio Nano Electronics Research Center, Graduate School of Interdisciplinary New Science Toyo University, Kawagoe, Saitama, 350-8585 JapanSearch for more papers by this author M. Sheikh Mohamed, M. Sheikh Mohamed Bio Nano Electronics Research Center, Graduate School of Interdisciplinary New Science Toyo University, Kawagoe, Saitama, 350-8585 JapanSearch for more papers by this authorSrivani Veeranarayanan, Srivani Veeranarayanan Bio Nano Electronics Research Center, Graduate School of Interdisciplinary New Science Toyo University, Kawagoe, Saitama, 350-8585 JapanSearch for more papers by this authorAnkur Baliyan, Ankur Baliyan Bio Nano Electronics Research Center, Graduate School of Interdisciplinary New Science Toyo University, Kawagoe, Saitama, 350-8585 JapanSearch for more papers by this authorAby Cheruvathoor Poulose, Aby Cheruvathoor Poulose Bio Nano Electronics Research Center, Graduate School of Interdisciplinary New Science Toyo University, Kawagoe, Saitama, 350-8585 JapanSearch for more papers by this authorYutaka Nagaoka, Yutaka Nagaoka Bio Nano Electronics Research Center, Graduate School of Interdisciplinary New Science Toyo University, Kawagoe, Saitama, 350-8585 JapanSearch for more papers by this authorHiroaki Minegishi, Hiroaki Minegishi Bio Nano Electronics Research Center, Graduate School of Interdisciplinary New Science Toyo University, Kawagoe, Saitama, 350-8585 JapanSearch for more papers by this authorSeiki Iwai, Seiki Iwai Bio Nano Electronics Research Center, Graduate School of Interdisciplinary New Science Toyo University, Kawagoe, Saitama, 350-8585 JapanSearch for more papers by this authorYasuhiro Shimane, Yasuhiro Shimane Bio Nano Electronics Research Center, Graduate School of Interdisciplinary New Science Toyo University, Kawagoe, Saitama, 350-8585 JapanSearch for more papers by this authorYasuhiko Yoshida, Yasuhiko Yoshida Bio Nano Electronics Research Center, Graduate School of Interdisciplinary New Science Toyo University, Kawagoe, Saitama, 350-8585 JapanSearch for more papers by this authorToru Maekawa, Toru Maekawa Bio Nano Electronics Research Center, Graduate School of Interdisciplinary New Science Toyo University, Kawagoe, Saitama, 350-8585 JapanSearch for more papers by this authorD. Sakthi Kumar, Corresponding Author D. Sakthi Kumar [email protected] Bio Nano Electronics Research Center, Graduate School of Interdisciplinary New Science Toyo University, Kawagoe, Saitama, 350-8585 JapanSearch for more papers by this author First published: 02 September 2014 https://doi.org/10.1002/mabi.201400248Citations: 18Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Abstract A nanoformulation composed of a ribosome inactivating protein-curcin and a hybrid solid lipid nanovector has been devised against glioblastoma. The structurally distinct nanoparticles were highly compatible to human endothelial and neuronal cells. A sturdy drug release from the particles, recorded upto 72 h, was reflected in the time-dependent toxicity. Folate-targeted nanoparticles were specifically internalized by glioma, imparting superior toxicity and curbed an aggressively proliferating in vitro 3D cancer mass in addition to suppressing the anti-apoptotic survivin and cell matrix protein vinculin. Combined with the imaging potential of the encapsulated dye, the nanovector emanates as a multifunctional anti-cancer system. Citing Literature Supporting Information As a service to our authors and readers, this journal provides supporting information supplied by the authors. Such materials are peer reviewed and may be re-organized for online delivery, but are not copy-edited or typeset. Technical support issues arising from supporting information (other than missing files) should be addressed to the authors. Filename Description mabi201400248-sm-0001-SuppFig-S1.docx276.4 KB Figure S1. Quantitative analysis of VNT-HSLNs uptake by cells pre-treated with specific endocytosis inhibitors. Though all the cells, showed significant levels of particle uptake, it was noteworthy that cytochalasin D, which inhibits the macropinocytosis and cavelolae mediated endocytosis, seemed to be somewhat restrictive to the HSLNs. Overall it seems that the particle exploit multiple pathways to access the cellular compartments. Figure S2. Quantification of cells exhibiting apoptosis/necrosis or both signals, post treatment with CT-HSLNs and stained with annexin/PPI. It is evident that the CT-HSLNs preferentially induced apoptosis and necrosis in the cancer cell line with a considerable percentage of cells exhibiting both symptoms. The normal cells on the other hand were immune to the toxic effects of encapsulated curcin as the particles did not gain entry into them. Figure S3. Corrected total cell florescence of survivin expression on exposure to CT-HSLNs. As evident from the plot, the level of survivin expression in glioma was highly diminished on treatment with CT-HSLNs, when compared to the normal cells. The significant loss of survivin expression in gliomas made them extremely vulnerable to chemotherapeutic agents as curcin. Figure S4. Corrected total cell florescence of vinculin expression on exposure to CT-HSLNs. As evident from the plot, the level of vinculin expression in glioma was greatly diminished on treatment with CT-HSLNs, when compared to the normal cells signifying the loss of cell-cell and cell-matrix adherent ability of the cancer cell line. Please note: The publisher is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article. Volume14, Issue12December 2014Pages 1696-1711 RelatedInformation
Referência(s)